News & Views
JSR Expands its Biomedical Business by Investing in BIA Separations' Unique Purification Technology
Feb 16 2012
JSR Corporation and BIA Separations have announced that they have entered a strategic partnership which includes a minor equity position by JSR on November 14th 2011. As a result of this investment, JSR and BIA Separations have started a joint global marketing and sales effort and collaborative R&D activities in the area of downstream purification as part of the manufacturing of vaccine, DNA and antibody based medicines.
From JSR’s perspective, teaming up with BIA Separations will give JSR access to a unique and leading edge technology in the field of downstream purification of large bio-molecules. Combining this technology with JSR’s proprietary Protein A media, the bio pharmaceutical industry will be offered afaster, more reliable downstream purification process at a lower cost of ownership. This will contribute to making advanced treatments
accessible to a larger part of the human society.
JSR’s global presence in the local markets and JSR’s expertise in the field of consistent high quality volume manufacturing will help BIA separations to successfully grow its business while maintaining its technological leadership.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK
May 21 2024 Lagos, Nigeria